(Q33878174)

29 July 2017

1 reference

title

HLA-DM and the MHC class II antigen presentation pathway (English)

1 reference

29 July 2017

Jensen PE

1

1 reference

29 July 2017

Weber DA

2

1 reference

29 July 2017

Thayer WP

3

1 reference

29 July 2017

Chen X

4

1 reference

29 July 2017

Dao CT

5

1 reference

29 July 2017

1 January 1999

1 reference

29 July 2017

1 reference

29 July 2017

20

1 reference

29 July 2017

3

1 reference

29 July 2017

195-205

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02790403

29 July 2017

0 references

cites work

Irreversible association of peptides with class II MHC molecules in living cells.

1 reference

12 December 2020

Lowering the tone: mechanisms of immunodominance among epitopes with low affinity for MHC.

1 reference

12 December 2020

Membrane interactions influence the peptide binding behavior of DR1.

1 reference

12 December 2020

Thermal stability comparison of purified empty and peptide-filled forms of a class I MHC molecule

1 reference

12 December 2020

Mapping functional regions in the lumenal domain of the class II-associated invariant chain

1 reference

12 December 2020

A role for peptide in determining MHC class II structure

1 reference

12 December 2020

Tolerance to a self-protein involves its immunodominant but does not involve its subdominant determinants

1 reference

12 December 2020

Mediation by HLA-DM of dissociation of peptides from HLA-DR.

1 reference

12 December 2020

Interaction of MHC class II molecules with the invariant chain: role of the invariant chain (81-90) region

1 reference

12 December 2020

Evidence that binding site occupancy is necessary and sufficient for effective major histocompatibility complex (MHC) class II transport through the secretory pathway redefines the primary function of class II-associated invariant chain peptides (CL

1 reference

12 December 2020

Stable association of processed antigen with antigen-presenting cell membranes

1 reference

12 December 2020

Isolation and characterization of antigen-la complexes involved in T cell recognition

1 reference

12 December 2020

Regulation of antigen presentation by acidic pH.

1 reference

12 December 2020

Defective processing and presentation of exogenous antigens in mutants with normal HLA class II genes

1 reference

12 December 2020

Editing of the HLA-DR-peptide repertoire by HLA-DM

1 reference

12 December 2020

Evidence for invariant chain 85-101 (CLIP) binding in the antigen binding site of MHC class II molecules

1 reference

12 December 2020

Crystal structure of mouse H2-M

1 reference

12 December 2020

Mice lacking H2-M complexes, enigmatic elements of the MHC class II peptide-loading pathway

1 reference

12 December 2020

Antigen presentation mediated by recycling of surface HLA-DR molecules.

1 reference

12 December 2020

Direct binding of autoimmune disease related T cell epitopes to purified Lewis rat MHC class II molecules

1 reference

12 December 2020

An autoantigenic T cell epitope forms unstable complexes with class II MHC: a novel route for escape from tolerance induction

1 reference

12 December 2020

Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM

1 reference

12 December 2020

Dominance and crypticity of T cell antigenic determinants

1 reference

12 December 2020

Identification of a sequence that mediates promiscuous binding of invariant chain to MHC class II allotypes

1 reference

12 December 2020

DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide

1 reference

12 December 2020

Structural features of the invariant chain fragment CLIP controlling rapid release from HLA-DR molecules and inhibition of peptide binding

1 reference

12 December 2020

Evidence for a conformational change in a class II major histocompatibility complex molecule occurring in the same pH range where antigen binding is enhanced

1 reference

12 December 2020

The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders

1 reference

12 December 2020

The human class II MHC protein HLA-DR1 assembles as empty alpha beta heterodimers in the absence of antigenic peptide

1 reference

12 December 2020

A critical, invariant chain-independent role for H2-M in antigen presentation

1 reference

12 December 2020

A europium fluoroimmunoassay for measuring binding of antigen to class II MHC glycoproteins

1 reference

12 December 2020

The CLIP region of invariant chain plays a critical role in regulating major histocompatibility complex class II folding, transport, and peptide occupancy

1 reference

12 December 2020

Long-lived complexes between peptide and class II major histocompatibility complex are formed at low pH with no requirement for pH neutralization

1 reference

12 December 2020

HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells

1 reference

12 December 2020

Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant

1 reference

12 December 2020

Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II.

1 reference

12 December 2020

Binding of immunogenic peptides to Ia histocompatibility molecules

1 reference

12 December 2020

A gene required for class II-restricted antigen presentation maps to the major histocompatibility complex

1 reference

12 December 2020

pH dependence and exchange of high and low responder peptides binding to a class II MHC molecule

1 reference

12 December 2020

A structural transition in class II major histocompatibility complex proteins at mildly acidic pH.

1 reference

12 December 2020

Kinetics of the reactions between the invariant chain (85-99) peptide and proteins of the murine class II MHC.

1 reference

12 December 2020

In the absence of the invariant chain, HLA-DR molecules display a distinct array of peptides which is influenced by the presence or absence of HLA-DM

1 reference

12 December 2020

Selective binding of bacterial toxins to major histocompatibility complex class II-expressing cells is controlled by invariant chain and HLA-DM.

1 reference

12 December 2020

The segment of invariant chain that is critical for association with major histocompatibility complex class II molecules contains the sequence of a peptide eluted from class II polypeptides

1 reference

12 December 2020

The structure of HLA-DM, the peptide exchange catalyst that loads antigen onto class II MHC molecules during antigen presentation

1 reference

12 December 2020

Invariant chain and DM edit self-peptide presentation by major histocompatibility complex (MHC) class II molecules

1 reference

12 December 2020

Functionality of major histocompatibility complex class II molecules in mice doubly deficient for invariant chain and H-2M complexes

1 reference

12 December 2020

Acidification and disulfide reduction can be sufficient to allow intact proteins to bind class II MHC.

1 reference

12 December 2020

Differential tolerance is induced in T cells recognizing distinct epitopes of myelin basic protein.

1 reference

12 December 2020

H2-M mutant mice are defective in the peptide loading of class II molecules, antigen presentation, and T cell repertoire selection

1 reference

12 December 2020

A kinetic intermediate in the reaction of an antigenic peptide and I-Ek

1 reference

12 December 2020

An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules

1 reference

12 December 2020

HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading

1 reference

12 December 2020

New class II-like genes in the murine MHC.

1 reference

12 December 2020

A new human HLA class II-related locus, DM

1 reference

12 December 2020

The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3

1 reference

12 December 2020

Self-release of CLIP in peptide loading of HLA-DR molecules

1 reference

12 December 2020

Invariant chain-independent function of H-2M in the formation of endogenous peptide-major histocompatibility complex class II complexes in vivo

1 reference

12 December 2020

Class II-associated invariant chain peptide-independent binding of invariant chain to class II MHC molecules.

1 reference

12 December 2020

HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides

1 reference

12 December 2020

Specificity pockets for the side chains of peptide antigens in HLA-Aw68

1 reference

12 December 2020

Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide

1 reference

12 December 2020

Enhanced binding of peptide antigen to purified class II major histocompatibility glycoproteins at acidic pH.

1 reference

12 December 2020

MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding

1 reference

12 December 2020

Antigen presentation and T cell development in H2-M-deficient mice

1 reference

12 December 2020

Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02790403

1 reference

Dimensions Publication ID

29 July 2017

0 references

1 reference